Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients

NCT03079947 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Peripheral T Cell Lymphoma

Sponsor

Peking Union Medical College Hospital